Autopsy report · NCT05237869

Blood Flow Restriction & Tennis Elbow Rehab

“Barriers to enrollment have been identified, including a lack of insurance coverage for occupational therapy. This study is being temporarily closed until funding can be secured to offset these costs for participants.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Suspended: paused, and may or may not restart.
• 250 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Julie Nuelle

Sponsor type

University, hospital or other

Conditions

Lateral Epicondylitis

Interventions

Blood Flow Restriction Device; Standard Physical Therapy

Participants

250 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae
  “Study closed due to lack of patient enrollment.” (62% match in meaning)
• Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers
  “Lack of efficacy and enrollment challenges” (61% match in meaning)
• The Metabolomics of Anaphylaxis
  “We are closing the study because of lack of enrollment.” (61% match in meaning)
• Does Optimized General Anesthesia Care Reduce Postoperative Delirium?
  “Limited availability of subjects meeting inclusion criteria resulting in early termination (lack of funding) before meeting target enrollment.” (60% match in meaning)
• A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
  “Study closed to enrollment due to low accrual.” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.